- Home
- INUV vs CLYM Comparison
INUV vs CLYM Comparison
Compare INUV & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INUV
- CLYM
- Stock Information
- Founded
- INUV N/A
- CLYM 2018
- Country
- INUV United States
- CLYM United States
- Employees
- INUV N/A
- CLYM N/A
- Industry
- INUV Advertising
- CLYM
- Sector
- INUV Consumer Discretionary
- CLYM
- Exchange
- INUV Nasdaq
- CLYM NYSE
- Market Cap
- INUV 75.7M
- CLYM 83.8M
- IPO Year
- INUV N/A
- CLYM 2021
- Fundamental
- Price
- INUV $4.94
- CLYM $1.52
- Analyst Decision
- INUV Strong Buy
- CLYM Buy
- Analyst Count
- INUV 2
- CLYM 1
- Target Price
- INUV $17.50
- CLYM $10.00
- AVG Volume (30 Days)
- INUV 129.6K
- CLYM 210.7K
- Earning Date
- INUV 08-11-2025
- CLYM 08-13-2025
- Dividend Yield
- INUV N/A
- CLYM N/A
- EPS Growth
- INUV N/A
- CLYM N/A
- EPS
- INUV N/A
- CLYM N/A
- Revenue
- INUV $93,478,114.00
- CLYM N/A
- Revenue This Year
- INUV $28.36
- CLYM N/A
- Revenue Next Year
- INUV $12.18
- CLYM N/A
- P/E Ratio
- INUV N/A
- CLYM N/A
- Revenue Growth
- INUV 18.20
- CLYM N/A
- 52 Week Low
- INUV $1.90
- CLYM $1.05
- 52 Week High
- INUV $7.90
- CLYM $8.87
- Technical
- Relative Strength Index (RSI)
- INUV 47.89
- CLYM N/A
- Support Level
- INUV $5.01
- CLYM N/A
- Resistance Level
- INUV $5.93
- CLYM N/A
- Average True Range (ATR)
- INUV 0.49
- CLYM 0.00
- MACD
- INUV -0.09
- CLYM 0.00
- Stochastic Oscillator
- INUV 8.28
- CLYM 0.00
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.